Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background: Immunocompromised patients face reactivation of latent viruses that increase the risk of morbidity. Aim: The study aimed to detect human herpes virus 6 (HHV-6) reactivation among allogeneic (allo) and autologous (auto) hematopoietic stem cell transplant (HSCT) recipients and to correlate potentially attributed clinical manifestations to HHV-6 DNA plasma level. Methods: A prospective study included all (forty) patients undergoing allo and auto-HSCT from Jan 2020 till June 2022. Plasma samples were collected for HHV-6 serology, and for HHV-6 quantitative PCR at post-transplantation weeks 2, 4, 6. Demographic and clinical data were recorded. Results: Out of 40 peripheral blood stem cell transplant (PBSCT) recipients, 34 (85%) were HHV-6 IgG positive pre-HSCT. Of which, fourteen patients (14/34, 41.2%) showed positive HHV-6 DNaemia. HHV-6 DNAemia (15/40, 37.5%) was significantly higher among allo (8/12, 66.7%) versus auto (7/28, 25%) HSCT recipients (p = 0.030). Patients with HHV-6 DNAemia developed fever, delayed engraftment and bone marrow suppression in 6/15, 40%, thrombocytopenia (5/15, 33.3%), rash and pneumonitis (2/15, 13.3%), acute GVHD (aGVHD) (1/15, 6.7%). HHV-6 DNAemia ranged from 101 to 102,000 copies/mL. Univariate analysis identified conditioning with busulfan–cyclophosphamide as a significant risk (p = 0.043), while receiving BEAM protocol was a protective factor (p = 0.045). In multivariate analysis, receiving BEAM protocol retained significance (p = 0.040). Conclusion: Frequent HHV-6 reactivation was detected after HSCT, especially in allo-HSCT recipients with clinical manifestations which could not be otherwise explained. To our best knowledge this is the first study of HHV6 reactivation in HSCT recipients from Egypt. Raising awareness for HHV-6 reactivation manifestations and screening in HSCT recipients could be lifesaving.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, HHV-6 associated with severe clinical outcomes has been described among immunocompromised individuals, with manifestations of encephalitis, hemophagocytic lymphohistiocytosis, long-term neurological sequelae, and mortality (26).”
From A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6 (2026) · cites this paper as [26]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
Zerr, D. M., Corey, L., Kim, H. W., Huang, M., Nguy, L., & Boeckh, M. (2005) · Clinical Infectious Diseases · doi:10.1086/428060 · Cited by 338 · cited 3×
“reported that sex-mismatched graft was significantly associated with HHV-6 reactivation [39].”
BackgroundResultLjungman, P., Wang, F.-Z., Clark, D. A., Emery, V. C., Remberger, M., Ringden, O., & Linde, A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02422.x · Cited by 196 · cited 2×
“Other studies demonstrated higher rates among allo-HSCT recipients (78%) [31] and among auto-HSCT recipients (41.”
ResultOgata, M., Satou, T., Kadota, J.-I., Saito, N., Yoshida, T., Okumura, H., Ueki, T., Nagafuji, K., Kako, S., Uoshima, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit358 · Cited by 196 · cited 3×
“detected HHV-6 DNA in plasma most frequently at 15–21 days after HSCT [13].”
BackgroundHuman Herpesvirus 6 Viremia in Bone Marrow Transplant Recipients: Clinical Features and Risk Factors
Yoshikawa, T., Asano, Y., Ihira, M., Suzuki, K., Ohashi, M., Suga, S., Kudo, K., Horibe, K., Kojima, S., Kato, K., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/339411 · Cited by 177 · cited 6×
“Similar results was demonstrated by many studies [24, 25, 36] Ogata et al.”
BackgroundResultInfluentialHill, J. A., Koo, S., Guzman Suarez, B. B., Ho, V. T., Cutler, C., Koreth, J., Armand, P., Alyea, E. P., Baden, L. R., Antin, J. H., et al. (2012) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2012.04.016 · Cited by 162
Impact of human herpesvirus‐6 after haematopoietic stem cell transplantation
Hentrich, M., Oruzio, D. V., Jäger, G., Schlemmer, M., Schleuning, M., Schiel, X., Hiddemann, W., & Kolb, H. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05254.x · Cited by 151 · cited 5×
“was illustrated to be significantly associated with delayed platelet engraftment and bone marrow suppression, aGVHD, and encephalitis in other studies [27, 31, 38].”
BackgroundResultInfluentialSashihara, J., Tanaka-Taya, K., Tanaka, S., Amo, K., Miyagawa, H., Hosoi, G., Taniguchi, T., Fukui, T., Kasuga, N., Aono, T., et al. (2002) · Blood · doi:10.1182/blood.v100.6.2005 · Cited by 149
HHV-6 Reactivation and Associated Sequelae after Hematopoietic Cell Transplantation
Zerr, D. M., Boeckh, M., Delaney, C., Martin, P. J., Xie, H., Adler, A. L., Huang, M.-L., Corey, L., & Leisenring, W. M. (2012) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2012.05.012 · Cited by 147 · cited 1×
“was illustrated to be significantly associated with delayed platelet engraftment and bone marrow suppression, aGVHD, and encephalitis in other studies [27, 31, 38].”
Latency, Integration, and Reactivation of Human Herpesvirus-6
Pantry, S., & Medveczky, P. (2017) · Viruses · doi:10.3390/v9070194 · Cited by 134 · cited 1×
“HHV-6 establishes latency in CD34 positive hematopoietic cells, such as monocytes, macrophages, bone marrow progenitors and T-cells [7, 8].”
Background
Research works printed but not linked: 3
- King O, Al Khalili Y. Herpes virus type 6. Treasure Island: StatPearls; 2020.
- IBM Corp Released. IBM SPSS statistics for Windows, Version 20.0. Armonk, NY: IBM Corp; 2011.
- Ouf NM, Abd M, Sattar EL, Sorady EL, Ghoneim FM, Moheb M, et al. Human cytomegalovirus in hematopoietic stem cell single experience. Senses Sci. 2022;9:1597–611.
Cited by
Abad, C. L. R., & Razonable, R. R. (2025) · Frontiers in Virology · doi:10.3389/fviro.2025.1641157 · Cited by 5
Perera, M., Varadhan, H., & Oon, A. (2026) · Microbiology spectrum · doi:10.1128/spectrum.00620-25 · Cited by 4
Kim, T. Y., Park, M., Yun, S. A., Kang, M., Kim, D. R., Shin, A., Kim, H., Jang, M., Jang, J., Kwon, M., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.04249-23 · Cited by 2
Kalantari, A., Karimizadeh, Z., Jafari, L., Behfar, M., & Hamidieh, A. A. (2025) · Seminars in Thrombosis and Hemostasis · doi:10.1055/a-2673-4266 · Cited by 1
“The drug-and infection-induced thrombocytopenia have been discussed in previous sections.”
Tang, J., Kang, Z., Cui, S., Xu, H., Ren, H., Li, P., Han, J., & Zou, Y. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.117196 · Cited by 1
Metadata
- Authors
- Raouf, M. M. E., Ouf, N. M., Elsorady, M. A. S., & Ghoneim, F. M.
- Affiliations
- Alexandria University (EG)
- Corresponding author
- Raouf, May Moheb Eldin
- Venue
- Virology Journal
- Published
- 2023-02-04
- Volume
- 20
- Issue
- 1
- Pages
- 20-20
- ISSN
- 1743-422X (ISSN-L)
- PMC
- PMC9899109
- OpenAlex
- W4319170656
- Cited by
- 9
- References
- 41
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 2
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Virology Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Alexandria University
- Topics
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Keywords
- human herpesvirus 6, HHV-6 reactivation, hematopoietic stem cell transplantation, allogeneic transplantation, autologous transplantation, immunocompromised patients, BEAM conditioning, busulfan and cyclophosphamide conditioning, graft-versus-host disease, delayed engraftment, thrombocytopenia
- MeSH terms
- Egypt, Humans, Prospective Studies, Herpesvirus 6, Human, Hematopoietic Stem Cell Transplantation, Roseolovirus Infections, Transplant Recipients
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt. https://app.cochat.ai/papers/10.1186/s12985-023-01980-w
- The paper
- Raouf, M. M. E., Ouf, N. M., Elsorady, M. A. S., & Ghoneim, F. M. (2023). Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt. Virology Journal. https://doi.org/10.1186/s12985-023-01980-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

